About

For Physicians
The standard of care for acute ischemic stroke in most of today's hospital stroke centers is the administering of a clot-busting medication tPA (tissue plasminogen activator) within 3 to 4 1/2 hours of symptom onset. However, if the patient has missed the opportunity for early care, or tPA treatment has failed to fully dissolve the clot, alternative lifesaving "inside-the-artery," interventional procedures exist that may be used up to eight hours after the start of symptoms. When clinically appropriate, specialists can use these procedures to physically remove the clot from the artery to restore blood flow to the brain.

This website was developed to educate the public on the importance of immediate medical attention for acute ischemic stroke, and to raise awareness of the range of treatment options available at more advanced Stroke Centers around the country.

To learn more about the Penumbra System®, and interventional clot removal with aspiration technology, please visit www.penumbrainc.com.

On average, a stroke occurs every 40 seconds in the United States.

But, did you know stroke can be treated if you get to the right hospital in time?

Quick, efficient stroke treatment (QuEST) is critical for ischemic stroke victims to help preserve brain cells and reduce the risk of long-term disability, or even death.

Share this site.

Stay Informed
Stay informed with alerts of new advanced Stroke Center openings.

Know Where to Go in Case Stroke Strikes. Join the QuEST.

Find an advanced Stroke Center with comprehensive treatment options near you.

About QuEST2StopStroke
QuEST2StopStroke.com is designed to educate the public on the clinical importance of treating ischemic stroke quickly and efficiently. In order to do this, patients should know where their closest advanced Stroke Center that offers comprehensive treatment options is located so that they may have access to the stroke therapy that meets their needs, as determined by their physician. This website is made possible by Penumbra, Inc., maker of the Penumbra System®.

The Penumbra System®, manufactured by Penumbra, Inc., is a device that enables complete blood clot removal and optimizes safety as it is removed from the body. The device has been FDA-cleared since December 2007 and has since been used in approximately 15,000 stroke procedures in the U.S. alone. The system is available in nearly 500 advanced Stroke Centers that offer comprehensive treatment options in the U.S.

For more information, please visit www.penumbrainc.com.

This site is governed by this Privacy Policy and Terms of Use.